Submission of intimation of re-constitution of committees.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals has reconstituted three key board committees — the Audit Committee, the Nomination & Remuneration Committee, and the Stakeholders Relationship Committee — effective April 12, 2025. The same three Non-Executive Independent Directors — Janardhan Das Kabra, Monam Kapoor, and Jivamohan Divakar Valluri — make up all three committees, with the chairperson role rotating between them. The reconstitution was approved at a board meeting held on the same day, which ran from 3:00 PM to 4:00 PM.
This is a routine governance update with no change in director composition. Shareholders should see no material impact on the stock, as all three committees continue to be fully composed of independent directors.